Medtelligence is dedicated to the creation of innovative, continuing medical education (CME) focusing on cardiovascular and cardiometabolic disease. Through the use of comprehensive, strategically aligned curricula, Medtelligence facilitates the sharing of research, knowledge, and clinical practice skills to engage medical practitioners to fulfill their commitment to lifelong professional development and ultimately improved patient care.
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD
Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD
Cutting-Edge Trials: TAVR for Small Aortic Annuli
Cutting-Edge Trials: TAVR for Small Aortic Annuli
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data
Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data
New Hope for TAVR: Overcoming Challenges for Women & Patients With Small Annuli
New Hope for TAVR: Overcoming Challenges for Women & Patients With Small Annuli
The BeAT Goes On: New Data on Improving Symptoms in HFrEF Patients Using Novel Device Therapy
The BeAT Goes On: New Data on Improving Symptoms in HFrEF Patients Using Novel Device Therapy
Complementary Treatment for Uncontrolled Hypertension: Using a Novel Blood Pressure Procedure
Complementary Treatment for Uncontrolled Hypertension: Using a Novel Blood Pressure Procedure
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
